ArticleJournal of Cancer2021

HOTAIR promotes gefitinib resistance through modification of EZH2 and silencing p16 and p21 in non-small cell lung cancer.

Weiting Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.